XML 90 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Apr. 30, 2018 $ 47,730 $ 6,841 $ 3,006 $ (53) $ 43,836 $ (5,900)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to Kewaunee Scientific Corporation 1,489       1,489  
Other comprehensive income (loss) (384)         (384)
Cash dividends paid (465)       (465)  
Stock options exercised   13 (13)      
Stock based compensation 106 7 99      
Ending balance at Jul. 31, 2018 48,693 6,861 3,092 (53) 45,077 (6,284)
Beginning balance at Apr. 30, 2018 47,730 6,841 3,006 (53) 43,836 (5,900)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to Kewaunee Scientific Corporation 2,821          
Other comprehensive income (loss) (1,108)          
Ending balance at Oct. 31, 2018 49,591 6,869 3,224 (53) 46,559 (7,008)
Beginning balance at Jul. 31, 2018 48,693 6,861 3,092 (53) 45,077 (6,284)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to Kewaunee Scientific Corporation 1,332       1,332  
Other comprehensive income (loss) (724)         (724)
Cash dividends paid (521)       (521)  
Stock options exercised   8 (8)      
Stock based compensation 140   140      
Ending balance at Oct. 31, 2018 49,591 6,869 3,224 (53) 46,559 (7,008)
Beginning balance at Apr. 30, 2019 47,100 6,875 3,133 (53) 43,552 (6,407)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to Kewaunee Scientific Corporation 471       471  
Other comprehensive income (loss) 195         195
Cash dividends paid (522)       (522)  
Stock based compensation 60 9 51      
Ending balance at Jul. 31, 2019 47,304 6,884 3,184 (53) 43,501 (6,212)
Beginning balance at Apr. 30, 2019 47,100 6,875 3,133 (53) 43,552 (6,407)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to Kewaunee Scientific Corporation (1,707)          
Other comprehensive income (loss) 18          
Ending balance at Oct. 31, 2019 44,468 6,884 3,226 (53) 40,800 (6,389)
Beginning balance at Jul. 31, 2019 47,304 6,884 3,184 (53) 43,501 (6,212)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to Kewaunee Scientific Corporation (2,178)       (2,178)  
Other comprehensive income (loss) (177)         (177)
Cash dividends paid (523)       (523)  
Stock based compensation 42   42      
Ending balance at Oct. 31, 2019 $ 44,468 $ 6,884 $ 3,226 $ (53) $ 40,800 $ (6,389)